Mitral Transcatheter Edge‐to‐Edge Repair in Younger Adults

Background Younger patients aged ≤65 years who have significant comorbidities deemed unsuitable for surgery, transcatheter edge‐to‐edge repair (TEER) may serve as an alternative, although the long‐term outcomes remain uncertain. This study aimed to compare clinical outcomes after TEER between younger patients (aged ≤65 years) and elderly patients (aged >65 years). Methods A retrospective analysis was performed on 1364 consecutive patients with mitral regurgitation. The primary end point was 3‐year all‐cause mortality. Optimal device success was defined as achieving mild or less residual mitral regurgitation and less than 5 mm Hg transmitral mean gradient. Results In the current cohort, 247 patients (18.1%) were younger than 65 years (median age: 58 years; interquartile ranges: 52–62), with 62.8% being men. Those younger patients had lower left ventricular ejection functions and were more likely to have secondary mitral regurgitation, congestive heart failure. Despite a higher‐risk clinical profile, composite of all‐cause mortality, heart failure hospitalization, or reintervention after TEER were comparable between younger and older patients. Younger patients demonstrated significantly lower 3‐year all‐cause mortality compared with older patients (18.5% versus 30.3%, P =0.007). Younger patients with device success had the lowest mortality compared with elderly patients with unsuccessful procedures (13.9% versus 34.3%, P =0.001). Among patients with unsuccessful procedures, TEER did not improve outcomes in younger patients compared with older patients. Propensity‐matched analysis confirmed that younger patients continued to demonstrate lower 3‐year all‐cause mortality (18.5% versus 34%, P =0.034). Conclusions Younger mitral regurgitation patients undergoing TEER had more advanced congestive heart failure but lower 3‐year mortality than elderly patients. However, those without optimal device success showed no survival benefit over their older counterparts, underscoring the need for close follow‐up and consideration of timely reintervention.

Authors

Institutions

Publication Details

Journal
Journal of the American Heart Association
Published
2026-08-20
DOI
https://doi.org/10.1161/jaha.125.043262
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mitral Transcatheter Edge‐to‐Edge Repair in Younger Adults

Mitch Gheorghiu, Sabah Skaf, Yuchao Guo, Hasan Jilaihawi et al.
Journal of the American Heart Association
Cardiac Valve Diseases and Treatments
article

Mitral Transcatheter Edge‐to‐Edge Repair in Younger Adults

Mitch Gheorghiu, Sabah Skaf, Yuchao Guo, Hasan Jilaihawi, Vivek Patel, Moody Makar, Hidemasa Shitan, Kazuki Suruga, Tarun Chakravarty, Aakriti Gupta, Takashi Nagasaka, Dhairya Patel, Wen Cheng, Mamoo Nakamura, Raj Makkar, Jair Basantes de la Calle
article en

Abstract

Background Younger patients aged ≤65 years who have significant comorbidities deemed unsuitable for surgery, transcatheter edge‐to‐edge repair (TEER) may serve as an alternative, although the long‐term outcomes remain uncertain. This study aimed to compare clinical outcomes after TEER between younger patients (aged ≤65 years) and elderly patients (aged >65 years). Methods A retrospective analysis was performed on 1364 consecutive patients with mitral regurgitation. The primary end point was 3‐year all‐cause mortality. Optimal device success was defined as achieving mild or less residual mitral regurgitation and less than 5 mm Hg transmitral mean gradient. Results In the current cohort, 247 patients (18.1%) were younger than 65 years (median age: 58 years; interquartile ranges: 52–62), with 62.8% being men. Those younger patients had lower left ventricular ejection functions and were more likely to have secondary mitral regurgitation, congestive heart failure. Despite a higher‐risk clinical profile, composite of all‐cause mortality, heart failure hospitalization, or reintervention after TEER were comparable between younger and older patients. Younger patients demonstrated significantly lower 3‐year all‐cause mortality compared with older patients (18.5% versus 30.3%, P =0.007). Younger patients with device success had the lowest mortality compared with elderly patients with unsuccessful procedures (13.9% versus 34.3%, P =0.001). Among patients with unsuccessful procedures, TEER did not improve outcomes in younger patients compared with older patients. Propensity‐matched analysis confirmed that younger patients continued to demonstrate lower 3‐year all‐cause mortality (18.5% versus 34%, P =0.034). Conclusions Younger mitral regurgitation patients undergoing TEER had more advanced congestive heart failure but lower 3‐year mortality than elderly patients. However, those without optimal device success showed no survival benefit over their older counterparts, underscoring the need for close follow‐up and consideration of timely reintervention.

Journal of the American Heart Association
Gunma University (JP), Cedars-Sinai Smidt Heart Institute (US), Second Affiliated Hospital of Zhejiang University (CN)
Good health and well-being
Openalex Percentile: Top 9%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.